Endogenous APP serves as a substrate that can be SUMO‐modified by PIAS1 in the hippocampus, affecting various processes related to AD. The interaction between PIAS1 and APP fragments like C83 and C99, which contain the AICD, influences Aβ degradation and pathological symptoms in AD. The gene discussed is APP; the disease is Alzheimer disease.